John Pickrell, MD
Cardiovascular Disease · Casper, WYNPI 1891748703
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 87.3% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $160, 5.4 times the $30 reported in 2019. That places this record below the midpoint for cardiovascular disease clinicians in WY, where the typical reported total is $1,181.
Across 22 payments — averaging $23.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$459
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$20
- Heartflow, Inc.$17
- E.r. Squibb & Sons, L.L.C.$15
- Medtronic$14
What the payments were for
- Food & beverage$526100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 18 | $459 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $20 |
| Heartflow, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Medtronic | 1 | $14 |
How this compares
$526 in reported general payments places this provider in the 35th percentile of 22 cardiovascular disease providers in Wyoming.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 534 | $536,719 |
| EntrestoSacubitril/Valsartan | 97 | $100,651 |
| XareltoRivaroxaban | 81 | $86,110 |
| Potassium Chloride | 218 | $4,134 |
| Atorvastatin Calcium | 473 | $3,674 |
| Digoxin | 115 | $3,525 |
| Flecainide Acetate | 80 | $3,354 |
| Nebivolol Hcl | 55 | $3,310 |
| Losartan Potassium | 297 | $2,744 |
| Carvedilol | 351 | $2,737 |
| Metoprolol Succinate | 263 | $2,511 |
| Lisinopril | 332 | $2,504 |
| Amlodipine Besylate | 349 | $2,249 |
| Dofetilide | 19 | $2,052 |
| Furosemide | 227 | $1,526 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Casper
- Michel SkafCasper$15K
- Robert NovickCasper$4K
- Adrian FlutureCasper$3K
- Allan WicksCasper$1K
- Oleg IvanovCasper$765
- David GonzalezAfton$6K
- Brian KellyPowell$4K
- Smitha NeerukondaCheyenne$3K
- Michael BrennanSheridan$3K
- William BrannEvanston$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.